Using an EGFPmeter to evaluate the lentiviral vector production: Tricks and traps

Methods in Molecular Biology

Volumn 515, Issue , 2009, Pages 151-163

  Bagnis, Claude ^a   Bailly, Pascal ^a   Chapel Fernandes, Sylvie ^a  

^a ETABLISSEMENT FRANÇAIS DU SANG   (France)

Author keywords

EGFP; Lentiviral vector; Titration assay; Viral vector production

Indexed keywords

ENHANCED GREEN FLUORESCENT PROTEIN; GREEN FLUORESCENT PROTEIN;

ARTICLE; CELL LINE; GENE VECTOR; GENETIC TRANSFECTION; GENETICS; HUMAN; KINETICS; LENTIVIRINAE; METABOLISM; METHODOLOGY; TITRIMETRY;

CELL LINE; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HUMANS; KINETICS; LENTIVIRUS; TITRIMETRY; TRANSFECTION;

EID: 65649130082     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-59745-559-6_10     Document Type: Article

References (18)

1. Bagnis, C., Uch, R. and Mannoni, P. (1999) Viral vectors and gene markers: tools and challenges for scientists working blind on genetic modification of hematopoietic cells. In:. Recent Research Developments in Virology. (Pandalai, S. G., ed.). Transworld Research Network:, Trivandrum1, pp. 217-228.
2. Bierhuizen, M. F., Westerman, Y., Visser, T. P., et al. (1997) Green fluorescent protein variants as markers of retroviral-mediated gene transfer in primary hematopoietic cells and cell lines. Biochem. Biophys. Res. Commun. 234, 371-375. (Pubitemid 27243910)
3. Zhang, G., Gurtu, V. and Kain, S. R. (1996) An enhanced green fluorescent protein allows sensitive detection of gene transfer in mammalian cells. Biochem. Biophys. Res. Commun. 227, 707-711. (Pubitemid 26387792)
4. Naldini, L., Blomer, U., Gallay, P., et al. (1996) In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272, 263-267. (Pubitemid 26119138)
5. Trono, D. (2000) Lentiviral vectors: turning a deadly foe into a therapeutic agent. Gene Ther. 7, 20-23. (Pubitemid 30077144)
6. Vigna, E. and Naldini, L. (2000) Lentiviral vectors: excellent tools for experimental gene transfer and promising candidates for gene therapy. J. Gene Med. 2, 308-316.
7. Zufferey, R. (2002) Production of lentiviral vectors. Curr. Top. Microbiol. Immunol. 261, 107-121. (Pubitemid 34259339)
8. Tiscornia, G., Singer, O. and Verma, I. M. (2006) Production and purification of lentiviral vectors. Nat. Protoc. 1, 241-245.
9. Demeneix, B. and Behr, J. P. (2005) Polyethylenimine (PEI). Adv. Genet. 53, 217-230.
10. Sastry, L., Johnson, T., Hobson, M. J., et al. (2002) Titering lentiviral vectors: comparison of DNA, RNA and marker expression methods. Gene Ther. 9, 1155-1162. (Pubitemid 34993938)
11. Geraerts, M., Willems, S., Baekelandt, V., et al. (2006) Comparison of lentiviral vector titration methods. BMC Biotechnol. 6, 34.
12. Hanazono, Y., Yu, J. M., Dunbar, C. E., et al. (1997) Green fluorescent protein retroviral vectors: low titer and high recombination frequency suggest a selective disadvantage. Hum. Gene Ther. 8, 1313-1319. (Pubitemid 27445412)
13. Roche, C., Zamora, A. J., Taieb, D., et al. (2004) Lentiviral vectors efficiently transduce human gonadotroph and somatotroph adenomas in vitro. Targeted expression of transgene by pituitary hormone promoters. J. Endocrinol. 183, 217-233. (Pubitemid 40124658)
14. Ngoi, S. M., Chien, A. C. Lee, C. G. (2004) Exploiting internal ribosome entry sites in gene therapy vector design. Curr. Gene. Ther. 4, 15-31. (Pubitemid 38854943)
15. Hildinger, M., Schilz, A., Eckert, H. G., et al. (1999) Bicistronic retroviral vectors for combining myeloprotection with cell-surface marking. Gene Ther. 6, 1222-1230. (Pubitemid 29359015)
16. Palsson, B. and Andreadis, S. (1997) The physico-chemical factors that govern retrovirus-mediated gene transfer. Exp. Hematol. 25, 94-102. (Pubitemid 27101322)
17. Liu, M. L., Winther, B. L. and Kay, M. A. (1996) Pseudotransduction of hepatocytes by using concentrated pseudotyped vesicular stomatitis virus G glycoprotein (VSV-G)-Moloney murine leukemia virus-derived retrovirus vectors: comparison of VSV-G and amphotropic vectors for hepatic gene transfer. J. Virol. 70, 2497-2502.
18. Haas, D. L., Case, S. S., Crooks, G. M., et al. (2000) Critical factors influencing stable transduction of human CD34+ cells with HIV-1 derived lentiviral vectors. Mol. Ther. 2, 71-80.